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Summary
Gender differences exist in outcomes, particularly early
mortality, for percutaneous interventions (PCI) and coronary
artery bypass graft surgery (CABG). Better understanding of
this issue may target areas for improvement for all patients un-
dergoing revascularization. Therefore, we summarized the ev-
idence on gender differences in PCI and CABG outcomes,
particularly early mortality, and mediators of this difference.
Using the key terms “women” or “gender,” “revasculariza-
tion,” “coronary artery bypass,” “angioplasty,” “stent,” and
“coronary intervention,” we searched MEDLINE from 1985
to 2005 for all randomized controlled trials (RCTs) and reg-
istries reporting outcomes by gender. Bibliographies and the
Web sites of cardiology conferences were also reviewed. The
literature was examined to identify gender differences in out-
comes and mediators of these differences. We identified 23
studies reporting outcomes by gender for CABG and 48 stud-
ies reporting outcomes by gender for PCI. The majority of
studies noted greater in-hospital mortality in women than in
men, with mortality differences resolving with longer follow-
up. Early mortality differences were reduced but not consis-
tently eliminated after adjustment for comorbidities, procedu-
ral characteristics, and body habitus. Power to detect gender
differences after multivariate adjustment was limited by de-
clining mortality rates and small sample size. Gender was an
independent risk factor for complications after both CABG
and PCI. Women experience greater complications and early
mortality after revascularization. Future exploration is needed
of gender differences in quality of care and benefit from com-
binations of stenting and antiplatelet, and anticoagulant med-
ications in order to optimize treatment.
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Introduction
In the United States in 2002, 373,000 men and 142,000 wo-
men underwent CABG and 802,000 men and 402,000 women
underwent a PCI, and these numbers are increasing.1 Women
may experience poorer outcomes, particularly greater early
mortality, than men. This may be related to women’s less favor-
able risk profile. However, it is unclear whether additional fac-
tors contribute to the difference. Further understanding of these
associations may identify opportunities to improve coronary
care.
In this review, we summarize the status of gender differ-
ences in morbidity and mortality after CABG and PCI. We
also summarize potential mediators of these differences. Fi-
nally, we present evidence on gender differences in specific as-
pects of periprocedural care that may affect outcomes, such as
use of stents and adjunctive medications.
Methods
To identify randomized trials, we reviewed MEDLINE 
references published between January 1, 1985, and March 31,
2005, in the subset of randomized controlled trials and human
subjects with these search terms: (women OR gender) AND
coronary disease AND (revascularization OR coronary artery
bypass OR stent) OR angioplasty OR coronary intervention)
which yielded 1,725 articles. To identify registries, we re-
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viewed MEDLINE references in the same period in the subset
of human subjects with the addition of “registry,” which yield-
ed 441 articles. We also reviewed reference lists and web
pages of cardiology conferences for articles not yet published.
Finally, we reviewed summaries published by the American
Heart Association, the European Heart Society, and the Coch-
rane Collaboration. We excluded studies that did not report
outcomes separately by gender or did not report on outcomes
by procedure. We excluded studies that only reported out-
comes by acute coronary syndrome (ACS) type, such as non-
ST-elevation myocardial infarction (NSTEMI) or STEMI, and
those that did not report on mortality or on a composite end-
point including mortality. Due to the small numbers of women
enrolled, lack of reporting by gender, and the relatively small
number of studies, we excluded studies examining only ex-
cimer laser angioplasty, directional atherectomy, cutting bal-
loon angioplasty, extraction atherectomy, vascular brachyther-
apy, and saphenous vein graft interventions. 
We identified 23 studies reporting outcomes by gender for
CABG and 48 studies reporting outcomes by gender for PCI;
in several instances, more than one report came from the same
database, and in these instances the largest dataset was report-
ed upon. 
Results
Gender Differences in Early Mortality
Unadjusted in-hospital mortality rates from PCI registries,
PCI trials, and CABG studies were higher in women than
men. The majority of studies demonstrated similar late mor-
tality between men and women. Several explanations have
been offered for the increased early mortality in women:
greater number of comorbidities and degree and type of vessel
involvement, smaller coronary vessel size and body habitus,
delayed intervention, less frequent use of arterial grafts, and
racial and socioeconomic differences. Adjustment for these
factors eliminated the gender difference in some studies, but
not in others. 
Comorbidities, anatomy, and early mortality: Women un-
dergoing PCI and CABG were on average older than men and
more often had diabetes, hypertension, congestive heart fail-
ure, and severe noncardiac disease. These factors, particularly
age, account for much of the gender difference in early mortal-
ity in studies of both PCI2 and CABG.3 Paradoxically, studies
have suggested that gender differences are greater in younger
than in older patients.4, 5 Diabetes may also have a greater ad-
verse impact on women than on men.6, 7 Lesion type and total
number of lesions may not be independently associated with
outcome after adjustment for other risk factors,8 but acknowl-
edgment of degree of vessel involvement (anatomy) as well as
clinical risk factors may be required to account for gender dif-
ferences.9 Of note, several PCI4, 8, 10, 11 and CABG12, 13 series
still demonstrated gender differences in early mortality after
adjustment for clinical and anatomical factors.
Smaller coronary arteries and body habitus: Since women
tend to have smaller coronary arteries than men, investigators
have explored vessel size as a mediator of women’s higher
mortality after CABG and PCI. Presumably, smaller vessel
size would be related to lower angiographic success and/or
greater periprocedural complications due to technical diffi-
culties. However, the relationship between vessel size and 
outcomes is inconsistent, with some studies showing differ-
ences3, 14 and others showing no differences.7, 15, 16 
When information on vessel size is not available, markers
for body habitus have sometimes been used as surrogates. In
one CABG registry, the correlation between body surface
area (BSA) and coronary artery size was 0.9,17 although oth-
er studies have found correlations as low as 0.1.18, 19 As with
studies adjusting for reference vessel size, studies examining
markers of body habitus and mortality are inconsistent. Sev-
eral CABG5, 20–22 and PCI23–25 studies have demonstrated as-
sociations between gender and mortality after adjustment for
body habitus, while other CABG3, 17, 26 and PCI11, 19, 27–31
studies have not. 
One explanation for the conflicting results may be that gen-
der differences in mortality are more pronounced with larger
BSA, and different studies may enroll patients with different
ranges of body habitus.22, 32, 33 In addition, Trabattoni et al.
found that restenosis rates after PCI were higher in women, de-
spite adjustment for BMI and risk factor differences. Of inter-
est is the fact that when they also considered final balloon size,
the magnitude of the gender difference was decreased.34 Final
balloon size, not BMI, was predictive of restenosis regardless
of gender.
Early intervention and referral: Some studies have shown
that women have longer times to PCI in the setting of isch-
emia,27, 35–37 although the effect on gender mortality differ-
ences was minimal. When disease is not as severe or more dif-
fuse, or morbidity is higher from related procedures after early
intervention such as unplanned CABG, men may benefit more
than women from early intervention.
Timing of referral for CABG may affect CABG outcomes.
Studies have suggested that women may be referred for
CABG less often than men, and possibly later in the course of
disease.37–41 It is difficult to determine if referral bias before
catheterization leads to increased clinical risk in women who
do undergo CABG, but the contribution to mortality appears to
be relatively small. 
Women may be referred less for elective CABG than 
men but may undergo emergent CABG more often, either as
the result of PCI complications or ACS.42 In turn, emergent
CABG is associated with greater mortality than nonemergent
CABG. Stents may be more likely to close in small vessels;
Watanabe et al. found that women were more likely to under-
go same-admission CABG after stent placement, presumably
because of complications or unsatisfactory angiographic re-
sults.43 However, more recent reports suggest that emergent
CABG may not be as important a factor in gender differences
in mortality.11, 16
Graft type and off-pump technology: Since arterial grafts
have higher patency rates, widespread use of arterial grafts in-
stead of saphenous vein grafts should reduce CABG mortality.
Women have lower rates of arterial, specifically internal tho-
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racic or mammary artery (IMA) use than men,15, 22, 33, 44 even
after adjustment for other factors such as age, nonelective
surgery, and extent of disease.15, 45 Thus, lower use of IMAs
could be a potential mediator of gender differences in out-
comes. However, the independent relationship with early mor-
tality is inconsistent, with some CABG series demonstrating
an association15, 26, 33 and others finding none.22, 45–47 Simil-
arly, the use of off-pump revascularization may improve
CABG outcomes, particularly periprocedural neurological
events,48 but it is unclear whether this effect is due to avoidance
of cardiopulmonary bypass and/or other aspects of healthcare
delivery, such as surgical skill. 
Income and race: Women have lower income than men, al-
though the effect of income as a mediator of gender differ-
ences in revascularization outcomes has not been widely stu-
died. In a Canadian registry, adjustment for women’s lower
income reduced but did not eliminate the 1-year gender differ-
ences in mortality after CABG.26 In an analysis of patients un-
dergoing PCI or CABG at the Cleveland Clinic, lower median
family income was associated with higher odds of receiving
PCI instead of CABG, but income was not associated with
mortality after either procedure.49
The interaction of race, gender, and outcomes has not been
widely studied. Of note, although racial and gender differ-
ences have been documented for revascularization, these have
not been associated with similar differences in mortality.50
Hartz et al. noted a significant interaction between race and
gender in the performance of CABG, but not in CABG mor-
tality.32 In another registry, black women were at lower risk
for a composite endpoint of death, MI, and revascularization
at 1 year than black men, with no gender difference among
white patients.16
Adjunctive periprocedural therapies: Glycoprotein inhib-
itors: Without exception, randomized trials of periprocedural
therapies are at least partially funded by the companies that
profit from these technologies. With this in mind, randomized
trials of glycoprotein IIb/IIIa inhibitors in conjunction with
PCI have generally found benefit in both men and women,
usually by a composite endpoint.51, 53 Gender differences may
vary with the specific glycoprotein inhibitor, although the dif-
ferences are small and the data are not consistent.54, 56 In con-
trast, the effect of IIb/IIIa inhibitors may differ for CABG,
with minimal benefit on mortality.57
Adjunctive periprocedural therapies: Stents: Studies of
outcomes after coronary stenting in new device trials or reg-
istries suggest improved outcomes in both men and women
when compared with past studies. As with glycoprotein in-
hibitors, firmer conclusions regarding the benefits of new
technologies are limited by power, lack of reporting by gen-
der, or both. Consequently, recent reductions in periprocedu-
ral mortality have made gender differences more difficult to
detect, but it is unclear how much of this is attributable to the
new technologies versus other improvements in care or pa-
tient selection.58 Despite overall reductions in periproced-
ural mortality,59 some studies suggest that women may not
benefit as much as men from revascularization with drug-
eluting stents.8, 60
Conclusions
Gender differences in outcomes are greatest for in-hospital
mortality. These differences are diminished after adjustment
for risk factors such as age and diabetes. Correction for body
habitus further diminishes the gender difference, although it is
unclear how body habitus influences mortality. It is unclear
how lower referral rates for women are related to their higher
risk profile and increased adverse outcomes. Finally, it is un-
known whether the uneven benefit of newer therapies, particu-
larly drug-eluting stents and glycoprotein inhibitors, is at-
tributable to gender differences in comorbidity patterns or
other factors. 
The American Heart Association’s 2005 Scientific State-
ment notes that women have increased in-hospital mortality
after both elective and primary PCI compared with men in the
majority of reports, but that such differences are smaller after
adjustment for women’s greater age, smaller BSA, and co-
morbidities at the time of presentation.59 Whether such differ-
ences are still significant after adjustment is unclear, since ap-
proximately half of the studies demonstrated persistently
elevated adjusted odds ratios with the lower bounds of the con-
fidence interval exceeding 1.59
The American Heart Association and the American Col-
lege of Cardiology, in collaboration with the American Asso-
ciation for Thoracic Surgery and the Society of Thoracic Sur-
geons, note that in-hospital CABG mortality is on average
greater in women than in men, and sometimes, but not always,
this disparity was reduced after adjustment for use of IMA
grafts, age, and BSA. However, the joint statement noted that
CABG compared with medical therapy still appeared to bene-
fit women in appropriately selected patients.47 The European
Society of Cardiology guidelines do not make specific recom-
mendations or statements regarding gender. No Cochrane Col-
laboration meta-analyses or statements on PCI or CABG have
examined gender-specific outcomes. 
Knowledge of the reasons for gender differences in out-
comes after coronary revascularization can optimize therapy
for all patients. The relative importance of factors in mediating
these gender differences, particularly early mortality, requires
studies that are adequately powered to conduct multivariate
risk adjustment, study of the interactions between therapy and
overall risk factor patterns, and closer inspection of processes
of care, particularly medication use, surrounding revascular-
ization. It is essential that clinical trials and registries report
gender-specific outcomes, as it is likely that predictors of risk,
including gender, will continue to evolve as procedure type
and patient risk profiles change. It is also important to make a
careful assessment of the influence of funding sources, as
studies of newer technologies are heavily reliant upon the
companies benefiting from these technologies.
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